Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies. (2022)

First Author: Allman M
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00415-022-11053-7

PubMed Identifier: 35286479

Publication URI: http://europepmc.org/abstract/MED/35286479

Type: Journal Article/Review

Volume: 269

Parent Publication: Journal of neurology

Issue: 4

ISSN: 0340-5354